top of page
gradientForSurfBreak.png

Item List

Buesinesswire
COMPaSS™ Personalized Spine Surgery Study Begins Enrollment

Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.

Recent Posts

Portfolio Company

Carlsmed.png

Where Is Ready, Set, Food! From Shark Tank Today?

Read More: https://www.thedai ...

Daily Meal

Portfolio Company

Carlsmed.png

Guardrails, data governance key to solid generative AI outcomes
...

Healthcare IT News

Portfolio Company

Carlsmed.png

At-Home Physical Therapy Leads to Better Recovery in Post-Surgical Patients, Stu ...

MedCity News

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page